Literature DB >> 12824091

Progression of chronic renal failure.

Henry T Yu1.   

Abstract

Chronic renal failure is characterized by a persistently abnormal glomerular filtration rate. The rate of progression varies substantially. Several morphologic features are prominent: fibrosis, loss of native renal cells, and infiltration by monocytes and/or macrophages. Mediators of the process include abnormal glomerular hemodynamics, hypoxia, proteinuria, hypertension, and several vasoactive substances (ie, cytokines and growth factors). Several predisposing host factors may also contribute to the process. Treatments to delay progression are aimed at treating the primary disease and at strictly controlling the systemic blood pressure and proteinuria. The role of antihypertensive agents, statins, and use of other maneuvers such as protein restriction and novel approaches are also discussed herein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824091     DOI: 10.1001/archinte.163.12.1417

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

Review 1.  Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence.

Authors:  Nicolas F Turek; Ana C Ricardo; James P Lash
Journal:  Am J Kidney Dis       Date:  2012-06-21       Impact factor: 8.860

2.  Effect of chronic dementia caregiving and major transitions in the caregiving situation on kidney function: a longitudinal study.

Authors:  Roland von Känel; Brent T Mausbach; Joel E Dimsdale; Paul J Mills; Thomas L Patterson; Sonia Ancoli-Israel; Michael G Ziegler; Susan K Roepke; Elizabeth A Chattillion; Matthew Allison; Igor Grant
Journal:  Psychosom Med       Date:  2012-01-27       Impact factor: 4.312

3.  Conservative Management of Chronic Renal Failure.

Authors:  A S Narula; A K Hooda
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.

Authors:  Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein
Journal:  Kidney Int       Date:  2011-08-24       Impact factor: 10.612

5.  The extra miles on preventing nephrogenic systemic fibrosis.

Authors:  A Adhipatria P Kartamihardja; Yoshito Tsushima
Journal:  Quant Imaging Med Surg       Date:  2019-11

6.  Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.

Authors:  Oliver Jung; Felix Jansen; Anja Mieth; Eduardo Barbosa-Sicard; Rainer U Pliquett; Andrea Babelova; Christophe Morisseau; Sung H Hwang; Cindy Tsai; Bruce D Hammock; Liliana Schaefer; Gerd Geisslinger; Kerstin Amann; Ralf P Brandes
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

7.  Inflammation and Progression of CKD: The CRIC Study.

Authors:  Richard L Amdur; Harold I Feldman; Jayanta Gupta; Wei Yang; Peter Kanetsky; Michael Shlipak; Mahboob Rahman; James P Lash; Raymond R Townsend; Akinlolu Ojo; Akshay Roy-Chaudhury; Alan S Go; Marshall Joffe; Jiang He; Vaidyanathapuram S Balakrishnan; Paul L Kimmel; John W Kusek; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

Review 8.  New perspectives in treatment of glomerulonephritis.

Authors:  Rosanna Coppo; Alessandro Amore
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

9.  Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis.

Authors:  Urara Mori-Takeyama; Shinya Minatoguchi; Ichijirou Murata; Hisayoshi Fujiwara; Yoko Ozaki; Michiya Ohno; Hiroshi Oda; Hiroshige Ohashi
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

10.  Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.

Authors:  Gregory L Hundemer; Navdeep Tangri; Manish M Sood; Tim Ramsay; Ann Bugeja; Pierre A Brown; Edward G Clark; Mohan Biyani; Christine A White; Ayub Akbari
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.